Background: The Global Anticoagulant Registry in the FIELD–Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. Methods and results: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012–2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 7...
Aim: A national atrial fibrillation (AF) registry was conducted under the aegis of the Indian Heart ...
BACKGROUND: Atrial fibrillation (AF) is associated with high rates of morbidity and mortality. Patie...
Background: Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoi...
Background: The Global Anticoagulant Registry in the FIELD–Atrial Fibrillation (GARFIELD-AF) is an o...
Background: The Global Anticoagulant Registry in the FIELD\u2013Atrial Fibrillation (GARFIELD-AF) is...
Background: The Global Anticoagulant Registry in the FIELD–Atrial Fibrillation (GARFIELD-AF) is an o...
BackgroundThe Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ong...
Background: Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoi...
BACKGROUND: Atrial fibrillation (AF) is the most common sustained arrhythmia with high risk for many...
<div><p>Background</p><p>Limited data are available on the characteristics, clinical management, and...
BackgroundWe report patient characteristics, treatment pattern and one-year clinical outcome of nonv...
Aim: A national atrial fibrillation (AF) registry was conducted under the aegis of the Indian Heart ...
BACKGROUND: Atrial fibrillation (AF) is associated with high rates of morbidity and mortality. Patie...
Background: Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoi...
Background: The Global Anticoagulant Registry in the FIELD–Atrial Fibrillation (GARFIELD-AF) is an o...
Background: The Global Anticoagulant Registry in the FIELD\u2013Atrial Fibrillation (GARFIELD-AF) is...
Background: The Global Anticoagulant Registry in the FIELD–Atrial Fibrillation (GARFIELD-AF) is an o...
BackgroundThe Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ong...
Background: Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoi...
BACKGROUND: Atrial fibrillation (AF) is the most common sustained arrhythmia with high risk for many...
<div><p>Background</p><p>Limited data are available on the characteristics, clinical management, and...
BackgroundWe report patient characteristics, treatment pattern and one-year clinical outcome of nonv...
Aim: A national atrial fibrillation (AF) registry was conducted under the aegis of the Indian Heart ...
BACKGROUND: Atrial fibrillation (AF) is associated with high rates of morbidity and mortality. Patie...
Background: Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoi...